Literature DB >> 466641

Amelioration of adriamycin skin necrosis: an experimental study.

M H Cohen.   

Abstract

Skin necrosis following subcutaneous Adriamycin extravasation is a significant clinical problem. In this study Adriamycin dilution and various drugs were tested for their ability to ameliorate this toxic effect. When Adriamycin was diluted to a concentration of less than or equal to 0.25 mg/ml, no skin ulceration was observed. Drugs such as hydrocortisone, dexamethasone, lidocaine, bupivacaine, phentolamine, and hyaluronidase were ineffective in modifying Adriamycin skin necrosis. Care in iv drug administration and dilution of Adriamycin are the best means of preventing the sequelae of subcutaneous Adriamycin extravasation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466641

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  4 in total

Review 1.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene.

Authors:  J P Daugherty; A Khurana
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.

Authors:  R T Dorr; D S Alberts; H S Chen
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Survival of intravenous chemotherapy infusion sites.

Authors:  J F Hecker
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.